Annual Drug Patent Expirations for TIVICAY
Tivicay is a drug marketed by Viiv Hlthcare and is included in two NDAs. It is available from three suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TIVICAY.
This drug has one hundred and twenty-four patent family members in thirty-three countries.
The generic ingredient in TIVICAY is dolutegravir sodium. Three suppliers are listed for this compound. Additional details are available on the dolutegravir sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com